title: Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis.
abstract: The exhaled breath of more than four hundred patients who presented at the Environmental Health Center - Dallas with chemical sensitivity conditions were analyzed for the relative abundance of their breath chemical composition by gas chromatography and mass spectrometry for volatile and semi-volatile organic compounds. All presenting patients had no fewer than four and as many as eight co-morbid conditions. Surprisingly, almost all the exhaled breath analyses showed the presence of a preponderance of lipophilic aliphatic and aromatic hydrocarbons. The hydrophilic compounds present were almost entirely of natural origin, i.e. expected metabolites of foods. The lipophile, primarily C3 to C16 hydrocarbons and believed to have come from inhalation of polluted air, were, in all cases, present at concentrations far below those known to be toxic to humans, but caused sensitivity and signs of chemical overload. The co-morbid health effects observed are believed to be caused by the sequential absorption of lipophilic and hydrophilic chemicals; an initial absorption and retention of lipophile followed by a subsequent absorption of hydrophilic species facilitated by the retained lipophile to produce chemical mixtures that are toxic at very low levels. It is hypothesized that co-morbid conditions in chemically sensitive individuals can be predicted from analysis of their exhaled breath.
authors.affiliation: Zeliger Chemical, Toxicological and Environmental Research, West Charlton, New York, USA.
authors.forename: Harold I
authors.initials: HI
authors.lastname: Zeliger
authors.forename: Yaqin
authors.initials: Y
authors.lastname: Pan
authors.forename: William J
authors.initials: WJ
authors.lastname: Rea
keywords: chemical mixtures; chemical sensitivity; exhaled breath analysis; sequential absorption; toxic chemicals
references.citation: Environ Health Perspect. 1993 Apr;100:169-76
references.pmid: 8354165
references.citation: Arch Environ Health. 2003 Jan;58(1):23-9
references.pmid: 12747515
references.citation: Am J Cardiol. 2004 Dec 15;94(12):1593-4
references.pmid: 15589029
references.citation: Breast J. 2003 May-Jun;9(3):184-91
references.pmid: 12752626
references.citation: Br J Ind Med. 1985 Mar;42(3):162-7
references.pmid: 3970880
references.citation: Proc Natl Acad Sci U S A. 1971 Oct;68(10):2374-6
references.pmid: 5289873
references.citation: Bol Asoc Med P R. 1991 Jul;83(7):316-20
references.pmid: 1817510
references.citation: Arch Toxicol. 1988;61(6):419-25
references.pmid: 3190439
references.citation: Chest. 2003 Jun;123(6):2115-23
references.pmid: 12796197
references.citation: Environ Sci Technol. 2007 Apr 1;41(7):2622-9
references.pmid: 17438825
references.citation: Clin Chim Acta. 2004 Jun;344(1-2):189-94
references.pmid: 15149888
references.citation: Anal Biochem. 1997 May 1;247(2):272-8
references.pmid: 9177688
references.citation: Lipids. 2001 Dec;36(12):1289-305
references.pmid: 11834080
references.citation: Drug Chem Toxicol. 2001 May;24(2):75-86
references.pmid: 11360436
references.citation: Arch Toxicol. 1998 Jul-Aug;72(8):483-91
references.pmid: 9765063